News

Discover a study that compared the safety of initiating immunotherapy before and during pollen peaks. Learn more.
Denmark-based allergy immunotherapy specialist ALK Abello (ALKB. DC) today announced that its Itulazax (tree pollen ...
ALK (ALKB.DC / OMX: ALK B) today announced that its European regulatory filing for ITULAZAX® (tree pollen sublingual allergy immunotherapy tablet) for treatment of young children and adolescents aged ...
People are not born allergic to things, but they can be born with a genetic tendency to become allergic to things to which ...